- SAMIL ESG
- Environmental Safety
- Labour and Human Rights
- Mutual Cooperation
- Social Contribution
- Ethical management
- Board of Directors
Ethical Management
We will prioritize corporate ethics and contribute to the well-being of humanity.
“Our mission is to enhance human life“
by developing safe and high-quality medicines, guided by a profound respect for life. To achieve this, we are committed to ongoing growth and development, while fulfilling our responsibilities as exemplary members of society. We pledge to establish and actively implement our Code of Ethics, with a focus on creating corporate social value and fostering ethical awareness as our primary objectives.
-
We fully embrace our corporate mission and are dedicated to developing highly effective and safe medicines through active investment in research and development.
-
We are committed to reliably producing and supplying medicines to meet the medical needs of our community. To achieve this, we will ensure that our drug production system adheres to international standards.
-
To establish fair competition and a transparent distribution system as required by society, we will reject all illegal and unfair transactions in the drug distribution process and foster cooperative relationships with healthcare professionals based on high ethical standards and transparency.
-
Recognizing the importance of accurate drug information in life-saving medical settings and patient medication guides, we strive to ensure that all information is evidence-based, clearly communicated, and designed to prevent misinterpretation, ensuring the safe use of medicines by consumers.
-
We conduct clinical trials and research to develop and improve medicines for the prevention and treatment of disease, while respecting the human rights of participants.
-
In addition to complying with national and international laws and regulations applicable to the pharmaceutical industry, we uphold treaties, declarations, and standards related to common human values, including anti-corruption, information security, human rights, and environmental protection.
-
We strive to perform our duties by prohibiting the pursuit of personal interests and eliminating conflicts of interest to ensure fair work. We are committed to fulfilling the social responsibilities entrusted to us by the company, and as part of this commitment, we actively engage in social contribution activities.
-
(Purpose)
The purpose of this policy is to establish an anti-corruption management system by setting standards of conduct for the organization and its members to prevent corruption and the acceptance of bribes. -
(Anti-Corruption)
The organization and its members are strictly prohibited from engaging in any form of corruption, including bribery, entertainment, or offering conveniences, to internal or external stakeholders under any pretext. -
(Compliance with anti-corruption laws and regulations)
The organization and its members shall comply with all relevant anti-corruption laws and regulations, including the “Legislation” and the following acts of the Republic of Korea: the “Pharmaceutical Affairs Act,” “Medical Service Act,” “Monopoly Regulation and Fair Trade Act,” “Prohibition of Improper Solicitation and Graft Act,” “Act on the Aggravated Punishment of Specific Economic Crimes,” and the “Act on Combating Bribery of Foreign Public Officials in International Business Transactions.” Additionally, we adhere to the “Foreign Corrupt Practices Act” of the United States, the “Bribery Act” of the United Kingdom, and all applicable domestic and foreign laws, international agreements, and internal regulations. -
(Alignment with organizational objectives)
The anti-corruption policy and management system established by the Company shall be formulated and adhered to in alignment with the Company's business objectives. -
(Establishment and communication of anti-corruption objectives)
The Company shall establish and adhere to an anti-corruption policy and system, and ensure its effective dissemination and communication so that employees, stakeholders, and business associates involved in the Company's operations are fully informed. -
(Commitment to Implement and Improve Anti-Corruption Measures)
The Company shall establish, operate, and continually enhance an effective anti-corruption management system to prevent and mitigate corruption risks. -
(Roles and Responsibilities of the Anti-Corruption Compliance Officer)
The Company grants the Anti-Corruption Compliance Officer independent responsibility and authority over anti-corruption matters. The Officer shall use this authority to provide advice, guidance, and oversight in addressing issues related to the anti-corruption management system. -
(Protection of Whistleblowers in Corruption Cases)
The Company will maintain the strict confidentiality of whistleblowers' personal information and will not retaliate against them through personnel actions or financial disadvantages for making a report. -
(Measures for Non-Compliance with the Anti-Corruption Policy)
The Company shall not be held liable for violations of regulations, guidelines, or laws related to this Policy committed by organizational members, nor for failures to take reasonable measures to prevent such violations once discovered. The Company may impose disciplinary actions on organizational members in accordance with applicable regulations
We welcome your valuable feedback and reports to support the continued development of Samil Pharmaceutical.
| Behaviors to be reported: |
Those involving Samil Pharmaceutical employees include:
|
|---|---|
| Protection of whistleblowers: |
|
| Creating a report: |
|
| How to report: |
|
| Handling Procedures: |
|
